NuPotential Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NuPotential Inc. - overview
Established
2004
Location
Baton Rouge, LA, US
Primary Industry
Healthcare
About
NuPotential Inc. is a biotechnology company dedicated to developing innovative cellular therapies and regenerative medicine products aimed at addressing significant healthcare challenges. Founded in 2004 in Baton Rouge, US, NuPotential Inc. focuses on biotechnology solutions, primarily in cellular therapies.
The company has successfully completed 2 deals, with its latest funding round occurring on May 3, 2014, where it raised USD 0. 375 million. The company is led by CEO Joan Neuscheler and was founded by Kenneth Eilertsen. NuPotential specializes in innovative solutions within the biotechnology sector, focusing primarily on advanced cellular therapies and regenerative medicine products.
Their flagship offerings include proprietary cell line technologies and therapeutic agents designed to enhance tissue regeneration and repair, addressing critical healthcare challenges such as chronic wound management, orthopedic injuries, and degenerative diseases. The company serves a diverse client base, including healthcare providers, research institutions, and pharmaceutical companies, mainly in North America and Europe. NuPotential generates revenue through a multi-faceted business model that encompasses B2B partnerships with healthcare institutions and direct sales to specialty clinics. The company’s revenue streams primarily include licensing agreements for their proprietary cell line technologies and sales of therapeutic products, ensuring a steady flow of income through structured contracts with clients committed to using NuPotential’s solutions in their treatment protocols.
NuPotential plans to leverage its recent funding of USD 0. 375 million raised on May 3, 2014, to support the development of new products and expansion into new markets. The company is currently designing additional therapeutic agents aimed at enhancing healing processes and plans to enter specific markets in North America and Europe by 2025. Through these initiatives, NuPotential aims to establish a robust presence in the biotechnology sector while driving overall growth.
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Hospitals
Website
www.nupotential.com
Total Amount Raised
Subscriber access only
NuPotential Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.